ArticlemedRxiv : the preprint server for health sciences2025
Hypothesis test of specific parametric structure in a generalized additive model.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Before applying flexible nonparametric models such as a generalized additive model (GAM), it is natural to ask whether a simpler parametric form suffices. To address this question, we develop TAPS (Test for Arbitrary Parametric Structure), a framework that integrates estimation and hypothesis testing to evaluate whether a prespecified parametric form adequately captures a covariate effect in a GAM. TAPS accommodates diverse structures, including linearity, piecewise linearity with changepoints, discontinuities with jumps, among many others. It is implemented in the R package mgcv.taps built directly on mgcv, enabling seamless adoption, broad outcome support, and scalability to biobank-scale data. Using UK Biobank data, we analyze 38 continuous and 8 binary traits to investigate two scientific questions: does the effect of a polygenic risk score (PRS) vary with age beyond a linear interaction, and does retirement at age 65 modify this age-varying effect? We find that age-varying PRS effects are common and often strongly non-linear, and that retirement at 65 significantly modifies these effects for five traits after multiple-testing correction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.